Understanding: How much is a 30-day prescription of Vraylar?

October 9, 2025 •

4 min read

The list price for a 30-day supply of Vraylar (cariprazine) was reported to be over $1,500 in early 2025, but the amount a patient actually pays for a 30-day prescription of Vraylar varies dramatically based on insurance coverage, pharmacy, and available savings programs. While the cash price is high, most patients do not pay the full retail amount, with many paying significantly less, or even nothing, with the right assistance.

Quick Summary

The monthly cost for Vraylar varies significantly based on insurance status and assistance programs. Without insurance, prices can exceed $2,000, while commercial insurance with a savings card can reduce the cost to $5 or less. Programs from the manufacturer and other services can also help lower expenses.

Key Points

High Retail Price: Without insurance, a 30-day supply of Vraylar can cost over $2,000, as there is no generic alternative.
Significant Insurance Coverage Variation: The final cost depends heavily on the specific insurance plan, coverage tier, and your progress through yearly plan stages.
VRAYPAY Savings Card for Commercial Insurance: Eligible commercially insured patients can use a savings card to pay as little as $0 for the first two fills and $5 for subsequent fills.
Medicare Part D Coverage: Medicare Part D typically covers Vraylar, but out-of-pocket costs can change throughout the year, with a $2,000 annual cap in 2025.
Medicaid Cost Most Medicaid patients pay a small copay, often $4 or less, though coverage and cost vary by state.
Manufacturer Patient Assistance Program (P.A.P.): The myAbbVie Assist program provides free medication to qualifying low-income, uninsured, or underinsured patients.
Discount Cards Offer Cash Price Savings: For those with high copays or no insurance, discount cards like SingleCare can lower the cash price, sometimes providing a better price than insurance.
No Generic for Vraylar: The active ingredient, cariprazine, is only available as a brand-name medication, contributing to its high price.

Factors Influencing the Cost of Vraylar

Several factors determine the final out-of-pocket cost for a 30-day prescription of Vraylar, making it crucial to explore all possible options before filling your prescription. The core elements affecting the price include your insurance status, the specific plan's coverage, the pharmacy you use, and whether you qualify for financial assistance programs.

The High Retail Price Without Insurance

For those without insurance or who choose not to use it, Vraylar is one of the more expensive atypical antipsychotic medications available. Because it is a brand-name drug with no generic equivalent yet, its retail price is high. Depending on the pharmacy and dosage (typically 1.5 mg), the average retail cost for a 30-day supply can range from approximately $1,400 to over $2,000. This price point can be a significant barrier for many patients, which is why exploring alternative payment methods is essential.

Navigating Cost with Insurance Coverage

Your type of health insurance is the single biggest factor in determining your monthly cost for Vraylar. Most plans offer some level of coverage, but the out-of-pocket expense can differ significantly:

Commercial/Private Insurance: Patients with commercial insurance are often eligible for the Vraylar Savings Program (VRAYPAY). With this program, eligible patients may pay as little as $0 for their first two 30-day fills, and as little as $5 for subsequent fills. The maximum annual benefit is often capped, but this program can drastically reduce monthly costs for those who qualify.
Medicare: Coverage for Vraylar falls under Medicare Part D. In 2025, Medicare has an annual out-of-pocket cap of $2,000 for covered prescriptions. The price you pay depends on your plan's formulary, tier placement (Vraylar is often higher-tier), and your progress through the coverage phases (deductible, initial coverage, catastrophic). The VRAYPAY savings card is not valid for Medicare patients.
Medicaid: Vraylar coverage varies by state and plan. Some state Medicaid plans may cover the entire cost, while others may require a small copay. The manufacturer notes that many Medicaid patients pay $4 or less per prescription. However, eligibility and terms are subject to change, so confirming with your state's program is necessary.

Exploring Financial Assistance and Discount Options

For those still facing high costs, several programs can offer financial relief:

Prescription Discount Cards: Services like SingleCare and GoodRx offer free coupons that can lower the cash price of Vraylar. A SingleCare coupon might reduce the cost to a range of $1,143 to $1,371, which can be a better option than a high insurance copay for some patients. These cards cannot be combined with insurance benefits.
Patient Assistance Program (P.A.P.): The manufacturer, AbbVie, runs a program called myAbbVie Assist, which provides free medication to eligible, low-income, uninsured, or underinsured patients who meet certain criteria.
90-Day Supply: Filling a 90-day supply of Vraylar instead of a 30-day supply may reduce the per-month cost and is often available through mail-order pharmacies, which can further reduce expenses.

Comparison of Vraylar Cost Scenarios


Payment Method	Typical 30-Day Cost	Eligibility and Conditions
Without Insurance	$1,400 - $2,000+ (Average retail price)	Varies significantly by pharmacy and dosage.
Commercial Insurance + VRAYPAY Card	As little as $0 (first 2 fills), then $5	Must have commercial insurance; not valid for government plans.
Discount Card (e.g., SingleCare)	~$1,143 - $1,371 (Based on coupons)	Can be used by insured or uninsured patients, but not with insurance benefits.
Medicare Part D	Varies (e.g., deductible, coinsurance)	Cost depends on plan, tier, and coverage phase. Cap is $2,000 in 2025.
Medicaid	Often $4 or less, possibly $0	Depends on state plan; many states have low copays.
myAbbVie Assist	$0 (if qualified)	Free for eligible low-income, uninsured, or underinsured patients.

Considering Alternatives to Vraylar

As Vraylar has no generic version, its high cost is persistent. However, several other atypical antipsychotics on the market have generic versions, which can be significantly more affordable. Options include:

Risperdal (risperidone): Generic versions are available and considerably cheaper.
Seroquel (quetiapine): Generic quetiapine is much more affordable than Vraylar.
Abilify (aripiprazole): Generic aripiprazole can lower monthly costs significantly compared to Vraylar.

It is crucial to discuss any medication change with your doctor to determine if a different drug is right for your condition and treatment plan.

Conclusion

While the sticker price for a 30-day supply of Vraylar can be staggering, few patients end up paying the full retail cost. The real question of "how much is a 30-day prescription of Vraylar" is highly dependent on your personal circumstances. By leveraging commercial insurance savings cards, exploring discount programs like SingleCare, or applying for the manufacturer's patient assistance program, the out-of-pocket expense can be managed. Always consult with your healthcare provider and pharmacist to evaluate which options best suit your financial situation and treatment needs.

For more information on the VRAYPAY Savings Program, visit the manufacturer's official website: VRAYLAR® (cariprazine) Cost and Savings.

Frequently Asked Questions

The average retail price for a 30-day supply of Vraylar without insurance typically ranges from $1,400 to over $2,000, depending on the pharmacy and dosage. Since it is a brand-name drug with no generic, the cash price is very high.

If you have commercial insurance, you can apply for the manufacturer's VRAYPAY Savings Card. Eligible patients may pay as little as $0 for initial fills and as low as $5 for subsequent 30- or 90-day fills.

Yes, Medicare Part D typically covers Vraylar. Your out-of-pocket cost will depend on your specific plan's formulary, tier placement, and your progression through the yearly coverage stages (deductible, initial coverage, etc.).

Yes, the manufacturer, AbbVie, offers the myAbbVie Assist program, which provides free Vraylar to qualifying low-income, uninsured, or underinsured patients. Eligibility is based on specific criteria.

Yes, discount cards can be used to purchase Vraylar at a reduced cash price. These discounts cannot be combined with your insurance, but for some people, the discounted price might be lower than their insurance copay.

No, a generic version of Vraylar (cariprazine) is not currently available. This is a primary reason for its high cost. Other atypical antipsychotics, however, do have generic alternatives.

Costs vary by state and specific plan. The manufacturer notes that most Medicaid patients will pay a small copay, often $4 or less, and some states may cover it completely. It's best to check with your state's Medicaid program.

Sometimes. Filling a 90-day supply, especially through a mail-order pharmacy, can potentially lower the cost per month and reduce pharmacy visits. You should check with your insurer and pharmacist about this option.